Predictive biomarkers for pathological complete response in early-stage triple negative breast cancer following neoadjuvant chemotherapy

被引：0
|
作者：
Polho, Gabriel Berlingieri
Testa, Laura
Barroso-Sousa, Romualdo
Bonadio, Renata Colombo
机构：
[1] Univ Sao Paulo, Inst Canc Estado Sao Paulo ICESP, Sao Paulo, Brazil
[2] Inst Canc Estado Sao Paulo ICESP, Sao Paulo, Brazil
[3] Grp Dasa, Brasilia, Brazil
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
598
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Utility of IHC-based markers for predicting pathological complete response in early-stage triple-negative breast cancer
    Funasaka, C.
    Kogawa, T.
    Sakamoto, N.
    Kusuhara, S.
    Nakao, T.
    Kondoh, C.
    Nakajima, H.
    Harano, K.
    Matsubara, N.
    Hosono, A.
    Naito, Y.
    Shimokawa, M.
    Watanuki, R.
    Yamashita, Y.
    Yamauchi, C.
    Onishi, T.
    Ishii, G.
    Mukohara, T.
    ANNALS OF ONCOLOGY, 2024, 35 : S1363 - S1363
  • [32] Predictive factors of pathological complete response to neoadjuvant therapy in triple-negative breast carcinoma
    Costa, J.
    Coimbra, N.
    Lopes, P.
    Antunes, L.
    Souto Moura, M.
    Leal, C.
    VIRCHOWS ARCHIV, 2020, 477 : S44 - S44
  • [33] Factors predicting a pathological complete response following neoadjuvant chemotherapy for breast cancer
    Choi, H.
    Van Belle, V.
    Wildiers, H.
    Paridaens, R.
    Amant, F.
    Van Limbergen, E.
    Moerman, P.
    Smeets, A.
    Vergote, I.
    Neven, P.
    EJC SUPPLEMENTS, 2010, 8 (03): : 66 - 67
  • [34] Multicontrast MRI-based radiomics for the prediction of pathological complete response to neoadjuvant chemotherapy in patients with early triple negative breast cancer
    Nemeth, Angeline
    Chaudet, Pierre
    Leporq, Benjamin
    Heudel, Pierre-Etienne
    Barabas, Fanny
    Tredan, Olivier
    Treilleux, Isabelle
    Coulon, Agnes
    Pilleul, Frank
    Beuf, Olivier
    MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE, 2021, 34 (06) : 833 - 844
  • [35] Multicontrast MRI-based radiomics for the prediction of pathological complete response to neoadjuvant chemotherapy in patients with early triple negative breast cancer
    Angeline Nemeth
    Pierre Chaudet
    Benjamin Leporq
    Pierre-Etienne Heudel
    Fanny Barabas
    Olivier Tredan
    Isabelle Treilleux
    Agnès Coulon
    Frank Pilleul
    Olivier Beuf
    Magnetic Resonance Materials in Physics, Biology and Medicine, 2021, 34 : 833 - 844
  • [36] The impact of chemotherapy relative dose intensity on pathological complete response in patients with triple negative breast cancer treated with neoadjuvant chemotherapy
    Buonaiuto, Roberto
    Neola, Giuseppe
    Caltavituro, Aldo
    Trasacco, Paola
    Mangiacotti, Federica Pia
    Pecoraro, Giovanna
    Lambertini, Matteo
    Pietroluongo, Erica
    De Placido, Pietro
    De Placido, Sabino
    Forestieri, Valeria
    Giuliano, Mario
    Arpino, Grazia
    De Angelis, Carmine
    CANCER RESEARCH, 2024, 84 (09)
  • [37] Impact of neoadjuvant systemic therapies on axillary response in early-stage triple-negative breast cancer
    Kook, Y.
    Minji, L.
    Moon, S.
    Ho, B. Seung
    Bae, S. J.
    Jeong, J.
    Ahn, S. G.
    ANNALS OF ONCOLOGY, 2024, 35 : S1408 - S1408
  • [38] Response to Neoadjuvant Chemotherapy of Triple Negative Breast Cancer
    Tokudome, N.
    Ito, Y.
    Takahashi, S.
    Sugihara, T.
    Hosonaga, M.
    Iwasaki, R.
    Hattori, M.
    Fukuda, T.
    Mitsuhashi, K.
    Kobayashi, K.
    Taira, S.
    Saito, Y.
    Fukada, I
    Ueki, N.
    Tsutsumi, C.
    Miyagi, Y.
    Iwase, T.
    Osako, T.
    Horii, R.
    Akiyama, F.
    Hatake, K.
    CANCER RESEARCH, 2009, 69 (24) : 571S - 572S
  • [39] Predictive score for response to neoadjuvant chemotherapy in early-stage HR + /HER2-breast cancer
    Coelho, Joao Queiros
    Lau, Beatriz
    Pichel, Rita
    Guerra, Laura
    Miranda, Hugo
    Romao, Raquel
    Sousa, Maria Joao
    Goncalves, Fernando
    Simoes, Joana
    Azevedo, Sergio Xavier
    Araujo, Antonio
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2025,
  • [40] Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response
    Loibl, S.
    Schneeweiss, A.
    Huober, J.
    Braun, M.
    Rey, J.
    Blohmer, J. U.
    Furlanetto, J.
    Zahm, D. M.
    Hanusch, C.
    Thomalla, J.
    Jackisch, C.
    Staib, P.
    Link, T.
    Rhiem, K.
    Solbach, C.
    Fasching, P. A.
    Nekljudova, V.
    Denkert, C.
    Untch, M.
    ANNALS OF ONCOLOGY, 2022, 33 (11) : 1149 - 1158
12345